MedTrace Logo

Insulin Secretory Capacity in Insulin-independent Pancreas-Kidney Recipients Compared to Controls

NCT00618761 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2012-06-15

No results posted yet for this study

Summary

The purpose of this study is to compare functional beta-cell mass using the hyperglycaemic clamp test in insulin-independent pancreas-kidney recipients with that in non-diabetic kidney recipients and normal controls as well as with the partially previously reported data in beta-cell recipients.

Conditions

  • Kidney Transplantation
  • Pancreas Transplantation

Interventions

OTHER

hyperglycemic clamp test

hyperglycemic clamp test

Sponsors & Collaborators

  • Juvenile Diabetes Research Foundation

    collaborator OTHER

  • Fund for Scientific Research, Flanders, Belgium

    collaborator OTHER

  • University Hospital, Gasthuisberg

    lead OTHER

Principal Investigators

  • Chantal Mathieu, M.D., PhD · UZ-Gasthuisberg, Department of Endocrinology

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2004-10-31
Primary Completion
2014-01-31
Completion
2014-01-31

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00618761 on ClinicalTrials.gov